Guerbet

Guerbet : H1 2025 revenue

24 7 2025 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet : Changes in the composition of the Guerbet board of directors.

25 5 2025 23:42:52 提供 Nasdaq GlobeNewswire

Guerbet: Q1 2025 revenue

24 4 2025 08:45:00 提供 Nasdaq GlobeNewswire

GUERBET : 2024 full-year results.

26 3 2025 09:45:00 提供 Nasdaq GlobeNewswire

DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan.

18 3 2025 09:45:00 提供 Nasdaq GlobeNewswire

GUERBET : 2024 revenue.

06 2 2025 08:45:00 提供 Nasdaq GlobeNewswire

GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF

03 2 2025 03:00:00 提供 Nasdaq GlobeNewswire

Correction: GUERBET : Financial agenda for 2025

31 10 2024 10:00:00 提供 Nasdaq GlobeNewswire

GUERBET : Revenue at September 30, 2024.

24 10 2024 08:45:00 提供 Nasdaq GlobeNewswire

GUERBET : H1 2024 results.

25 9 2024 08:45:00 提供 Nasdaq GlobeNewswire

GUERBET : H1 2024 revenue.

25 7 2024 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.

24 5 2024 08:44:58 提供 Nasdaq GlobeNewswire

Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics.

22 5 2024 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet : Q1 2024 revenue.

25 4 2024 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet: Financial agenda for 2024

15 1 2024 09:00:00 提供 Nasdaq GlobeNewswire

GUERBET : Revenue at 30 September 2023.

19 10 2023 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet: CHMP positive opinion

12 10 2023 08:57:24 提供 Nasdaq GlobeNewswire

Guerbet: 2023 half-year results

20 9 2023 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet: First-half 2023 revenue

20 7 2023 08:46:36 提供 Nasdaq GlobeNewswire

Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

17 7 2023 10:00:19 提供 Nasdaq GlobeNewswire